Physician profile
Daniel Murariu
NPI 1518127984
$238,298.30
in general payments reported to CMS, 2019-2025
20 companies · $29K in 2025
The $29K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $18K · 2021: $16K · 2022: $73K · 2023: $61K · 2024: $30K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $103K · Travel and Lodging: $12K · Food and Beverage: $4,177 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $103,462.94 |
| Travel and Lodging | $11,869.35 |
| Food and Beverage | $4,177.48 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $214,201.95 | 2019-2025 | |
| Sientra, INC. | $17,738.60 | 2020-2022 | |
| Integra Lifesciences Corporation | $2,372.15 | 2020-2024 | Codman Certas, Surgimend, Durasorb Monofilament Mesh |
| Smith+Nephew, INC. | $790.04 | 2019-2025 | Grafix Pl, Grafix, Stravix |
| Axogen | $685.48 | 2019-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Abbvie INC. | $645.56 | 2023-2025 | |
| Tela Bio, INC. | $329.76 | 2019-2022 | |
| Revance Therapeutics, INC. | $231.62 | 2024-2025 | Daxxify |
| Tactile Systems Technology INC | $214.62 | 2021-2022 | |
| Kls-Martin L.P. | $199.45 | 2020-2022 | |
| Motiva USA, LLC | $186.58 | 2025 | |
| Allergan, INC. | $183.88 | 2019-2022 | |
| Medtronic, INC. | $182.80 | 2023 | Mazor X System |
| Mentor Worldwide LLC | $143.52 | 2019-2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $48.70 | 2023-2024 | Clear & Brilliant |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $46.39 | 2023-2024 | Xeomin |
| Next Science LLC | $32.32 | 2024 | Surgx, Blastx, Xperience |
| Vioptix INC | $32.20 | 2025 | |
| Innovation Technologies INC | $21.00 | 2019 | |
| Misonix INC | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Murariu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.